This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jorgensen, J H Articles by Alexander, G A Search for Related Content PubMed PubMed Citation Articles by Jorgensen, J H Articles by Alexander, G A

 Previous Article

Antimicrob Agents Chemother. 1980 May; 17(5): 901-904

Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.

J H Jorgensen, S A Crawford and G A Alexander

ABSTRACT

The in vitro activities of moxalactam (LY127935 [6059S]) and cefotaxime were compared with those of cefoxitin, cefamandole, cefuroxime, carbenicillin, and penicillin by agar dilution susceptibility testing of a variety of anaerobic bacteria. Moxalactam proved to be the most active agent tested against Bacteroides fragilis and other species of the B. fragilis group. Moxalactam and cefotaxime showed activity similar to the other drugs against the remaining species of Bacteroides, Fusobacterium, Actinomyces, Propionibacterium, and Veillonella. Penicillin was the most effective drug tested against most species of Clostridium, the anaerobic gram-positive cocci, and Eubacterium lentum.

---

Antimicrob Agents Chemother. 1980 May; 17(5): 901-904

This article has been cited by other articles:

• Paker, G. E., Graham, J. A., Rauch, A. M., Collins, J. J. (1994). Cefuroxime Axetil in the Treatment of Sinusitis: A Review. Arch Fam Med 3: 165-175 [Abstract]  
• Fett, D. R., Silverman, C. A., Yoshizumi, M. O. (1984). Moxalactam Retinal Toxicity. Arch Ophthalmol 102: 435-438 [Abstract]